NewsNovo
The case for reading TuHURA Biosciences' (HURA) latest board action as a hiring signal is reasonable.
The complication: 5,000,000 shares of common stock reserved for new-employee equity grants, adopted September 10, 2026, without a stockholder vote, raises dilution arithmetic that any holder should run before filing this one away.
The Board of Directors adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan on September 10, relying on Nasdaq Listing Rule 5635(c)(4) to bypass the standard shareholder approval requirement.
That rule permits inducement grants to new hires without a broader vote, provided the Compensation Committee, seated entirely with independent directors, controls the award process.
Keep reading